GIG OpenIR  > 中国科学院矿物学与成矿学重点实验室  > 期刊论文
Li, Juan; Tian, Shuangyan; Tao, Qi; Zhao, Yawen; Gui, Ruyi; Yang, Fan; Zang, Lingquan; Chen, Yanzhong; Ping, Qineng; Hou, Dongzhi
Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Source PublicationINTERNATIONAL JOURNAL OF NANOMEDICINE
ISSN1178-2013
2018
Volume13Pages:3975-3987
DOI10.2147/IJN.S162306
Indexed BySCI
Language英语
WOS IDWOS:000438450100001
Citation statistics
Cited Times:7[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.gig.ac.cn/handle/344008/37027
Collection中国科学院矿物学与成矿学重点实验室_期刊论文
Recommended Citation
GB/T 7714
Li, Juan,Tian, Shuangyan,Tao, Qi,et al. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE,2018,13:3975-3987.
APA Li, Juan.,Tian, Shuangyan.,Tao, Qi.,Zhao, Yawen.,Gui, Ruyi.,...&Hou, Dongzhi.(2018).Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.INTERNATIONAL JOURNAL OF NANOMEDICINE,13,3975-3987.
MLA Li, Juan,et al."Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma".INTERNATIONAL JOURNAL OF NANOMEDICINE 13(2018):3975-3987.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Li, Juan]'s Articles
[Tian, Shuangyan]'s Articles
[Tao, Qi]'s Articles
Baidu academic
Similar articles in Baidu academic
[Li, Juan]'s Articles
[Tian, Shuangyan]'s Articles
[Tao, Qi]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Li, Juan]'s Articles
[Tian, Shuangyan]'s Articles
[Tao, Qi]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.